Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- Experimental AIDS Vaccine Promising
- Experimental Merck Drug Improves Cholesterol Levels: Study
- Expert: ‘Persistent Uncertainty’ About H1N1’s Next Moves
- Express Scripts, Other PBMs Go Data-Diving to Predict Health Problems
- Extended-Release Antipsychotics, for Extended Patent Protection
- Extraordinary Measures: Biotech Goes to Hollywood
- Eyeborg: The Future of Prosthetics?
- Face Transplants: Further Reading
- Facebook Launches Organ Donation Program
- Facebook Lets Users Chat With Suicide-Prevention Counselors
- Faces of Health Care: A Doctor is in the House
- Faces of Health Care: Belgium Does it Cheaper
- Faces of Health Care: Buying Meds South of Border
- Faces of Health Care: Generous Insurance Coverage
- Faces of Health Care: Helped by Government Aid
- Faces of Health Care: Leukemia Leads to Bankruptcy
- Faces of Health Care: Liberty, but No Coverage
- Faces of Health Care: Living with Lyme Disease
- Faces of Health Care: No Experimental Treatments
- Faces of Health Care: No Insurance, No Babies
- Faces of Health Care: On a Ledge Without Insurance
- Faces of Health Care: Too Late to Save Her Father
- Faces of Health Care:Nanny's Life Without Benefits
- Faces of Health Care:Yellow Cab, but No Blue Cross
- Fake Drugs Found On Sale in U.S. Market
- Fancy Tools for Tracking the Flu
- Farrah Fawcett’s Death Spotlights Rare Cancer Type
- Fashion’s Super-Thin Back in Focus After Israeli Ban
- Fatal Swine Flu Breaks Out in Mexico
- Faulty ALS Diagnosis Scares Veterans
- Faulty Defibrillator Wires Prompt Call for More Monitoring
- FBI Agent, 19 Others Vote Against Jazz Pharma’s Drug For Fibromyalgia
- FBI: Personal Injury Lawyer Paid for Hospital Patients’ Records
- FDA (Finally) Gives Amylin’s Bydureon a Thumbs-Up
- FDA Advances Merck’s Gardasil for Men, Glaxo’s Cervarix
- FDA Advisory Committee Chair Weighs in on L’Affaire ReGen
- FDA Advisory Committee to Hear About XMRV Working Group’s Research
- FDA Advisory Panel Gives Thumbs-Up to AstraZeneca’s Brilinta
- FDA Advisory Panel Renders Split Decision on Abbott’s Meridia
- FDA Allows Cheaper Version of Preterm Labor Drug To Stay on the Market
- FDA Approves Gardasil Vaccine for Boys, Cervarix for Girls
- FDA Approves New Suppliers for Scarce Cancer Drugs
- FDA Approves Pump For Young Heart-Failure Patients
- FDA Approves Vertex’s Kalydeco, But It Won’t Come Cheap
- FDA Chief: ‘Violations Have Gone Unaddressed for Far Too Long’
- FDA Clears iPad Radiology App; Doctors, What’s Your Dream App?
- FDA Closer to Regulating Cigarettes
- FDA Commissioner: Use Generic Alternatives to Recalled J&J Meds
- FDA Database Aims to Spark Orphan-Disease Drug Development
- FDA Dings Novartis for Facebook Widget
- FDA Discourages Use of Some Asthma Drugs After Years of Review
- FDA Documents Question Avodart’s Prostate-Cancer Prevention Power
- FDA Drug Approvals in 2009: Up (a Little) from 2008
- FDA Egg Farm Inspection Reports Include Rodents, Flies, 8-Foot-High Manure Pile
- FDA Finds Problems With Insulin Pumps ‘Across Manufacturers’
- FDA Grants Mom’s Wish; Gives Orphan Drug Designation
- FDA Guidance: Non-Medical Antibiotic Use in Animals a Bad Idea
- FDA Has (Some) Social Media Advice For Pharma
- FDA Identifies More Problems at J&J Plant
- FDA in Hot Seat on Heart-Device Safety
- FDA Inspection Report Cited 20 Violations for J&J
- FDA Isn’t Ready to Approve J&J Anticlotting Drug
- FDA Issues Warning Letters Over Tysabri, ‘Lipodissolve’ Injections
- FDA Looks at Antibacterial Soap for Hormone Effects
- FDA Looks to Streamline Rules for New Drug Cocktails
- FDA Medical Device Review Process: Too Fast or Too Slow?
- FDA Message on Drug Ads: Don’t Bury Risk Information
- FDA Mulling End to Avandia-Actos Trial on Safety Worries
- FDA Nixes Vivus’s Qnexa; Asks For More Safety Data
- FDA OKs New Treatment for Soft-Tissue Sarcoma Patients
- FDA Panel Likes Acorda’s Multiple Sclerosis Drug
- FDA Panel Math: How Avandia Vote is Being Played
- FDA Panel OKs More Antipsychotics for Children
- FDA Panel Recommends Approval of Lupus Drug Benlysta
- FDA Panel Recommends Orexigen’s Contrave Weight-Loss Drug
2009 -